{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:25:49Z","timestamp":1793139949955,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Provincial Research Hospital","award":["YJXYY202204-YSB36"],"award-info":[{"award-number":["YJXYY202204-YSB36"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-024-00575-x","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T01:39:03Z","timestamp":1734572343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prostatitis, benign prostatic hyperplasia, and prostate cancer: a bidirectional Mendelian randomization study and clinical implications for these patients\u2019 populations"],"prefix":"10.1186","volume":"19","author":[{"given":"Yi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5308-6977","authenticated-orcid":false,"given":"Dongliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7466-908X","authenticated-orcid":false,"given":"Qianwei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"issue":"21","key":"575_CR1","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1080\/10408398.2021.2013158","volume":"63","author":"A Gasmi","year":"2023","unstructured":"Gasmi A, Bj\u00f8rklund G, Noor S, Semenova Y, Dosa A, Pen JJ, Menzel A, Piscopo S, Wirth N, Costea DO. Nutritional and surgical aspects in prostate disorders. Crit Rev Food Sci Nutr. 2023;63(21):5138\u201354.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"3","key":"575_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"2","key":"575_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, Bray F, Brawley O, Luckenbaugh AN, Mucci L, et al. 2022 update on prostate Cancer epidemiology and risk Factors-A systematic review. Eur Urol. 2023;84(2):191\u2013206.","journal-title":"Eur Urol"},{"issue":"1","key":"575_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrurol.2012.192","volume":"10","author":"DD \u00d8rsted","year":"2013","unstructured":"\u00d8rsted DD, Bojesen SE. The link between benign prostatic hyperplasia and prostate cancer. Nat Reviews Urol. 2013;10(1):49\u201354.","journal-title":"Nat Reviews Urol"},{"issue":"4","key":"575_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11934-008-0056-6","volume":"9","author":"JS Sandhu","year":"2008","unstructured":"Sandhu JS. Prostate cancer and chronic prostatitis. Curr Urol Rep. 2008;9(4):328\u201332.","journal-title":"Curr Urol Rep"},{"issue":"9","key":"575_CR6","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1038\/bjc.2013.184","volume":"108","author":"SC Hung","year":"2013","unstructured":"Hung SC, Lai SW, Tsai PY, Chen PC, Wu HC, Lin WH, Sung FC. Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk. Br J Cancer. 2013;108(9):1778\u201383.","journal-title":"Br J Cancer"},{"issue":"1","key":"575_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7150\/jca.37235","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wang Y, Qin Z, Gao X, Xing Q, Li R, Wang W, Song N, Zhang W. Correlation between Prostatitis, Benign Prostatic Hyperplasia and prostate Cancer: a systematic review and Meta-analysis. J Cancer. 2020;11(1):177\u201389.","journal-title":"J Cancer"},{"issue":"2","key":"575_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.5534\/wjmh.190135","volume":"39","author":"SH Kim","year":"2021","unstructured":"Kim SH, Kwon WA, Joung JY. Impact of Benign Prostatic Hyperplasia and\/or Prostatitis on the risk of prostate Cancer in Korean patients. World J men\u2019s Health. 2021;39(2):358\u201365.","journal-title":"World J men\u2019s Health"},{"issue":"12","key":"575_CR9","doi-asserted-by":"publisher","first-page":"103210","DOI":"10.1016\/j.autrev.2022.103210","volume":"21","author":"C Chen","year":"2022","unstructured":"Chen C, Wang P, Zhang RD, Fang Y, Jiang LQ, Fang X, Zhao Y, Wang DG, Ni J, Pan HF. Mendelian randomization as a tool to gain insights into the mosaic causes of autoimmune diseases. Autoimmun rev. 2022;21(12):103210.","journal-title":"Autoimmun rev"},{"issue":"5","key":"575_CR10","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/humupd\/dmad009","volume":"29","author":"IM McGrath","year":"2023","unstructured":"McGrath IM, Montgomery GW, Mortlock S. Insights from mendelian randomization and genetic correlation analyses into the relationship between endometriosis and its comorbidities. Hum Reprod Update. 2023;29(5):655\u201374.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"575_CR11","doi-asserted-by":"publisher","first-page":"e28208","DOI":"10.1002\/jmv.28208","volume":"95","author":"JX Sun","year":"2023","unstructured":"Sun JX, Xu JZ, Liu CQ, An Y, Xu MY, Zhong XY, Zeng N, Ma SY, He HD, Hu J, et al. The association between human papillomavirus and bladder cancer: evidence from meta-analysis and two-sample mendelian randomization. J Med Virol. 2023;95(1):e28208.","journal-title":"J Med Virol"},{"key":"575_CR12","doi-asserted-by":"crossref","unstructured":"Shen S, Gao X, Song X, Xiang W. Association between inflammatory bowel disease and rosacea: a bidirectional two-sample mendelian randomization study. J Am Acad Dermatol 2023.","DOI":"10.1016\/j.jaad.2023.10.003"},{"issue":"5","key":"575_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","volume":"36","author":"AR Carter","year":"2021","unstructured":"Carter AR, Sanderson E, Hammerton G, Richmond RC, Davey Smith G, Heron J, Taylor AE, Davies NM, Howe LD. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol. 2021;36(5):465\u201378.","journal-title":"Eur J Epidemiol"},{"issue":"11","key":"575_CR14","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/j.jid.2017.07.817","volume":"137","author":"R Noordam","year":"2017","unstructured":"Noordam R, Hamer MA, Pardo LM, van der Nat T, Kiefte-de Jong JC, Kayser M, Slagboom PE, Uitterlinden A, Zillikens MC, Beekman M, et al. No Causal Association between 25-Hydroxyvitamin D and features of skin aging: evidence from a bidirectional mendelian randomization study. J Invest Dermatol. 2017;137(11):2291\u20137.","journal-title":"J Invest Dermatol"},{"key":"575_CR15","doi-asserted-by":"crossref","unstructured":"Zhong H, Liu S, Zhu J, Xu TH, Yu H, Wu L. Elucidating the role of blood metabolites on pancreatic cancer risk using two-sample mendelian randomization analysis. Int J Cancer 2023.","DOI":"10.1002\/ijc.34771"},{"key":"575_CR16","doi-asserted-by":"publisher","first-page":"1185466","DOI":"10.3389\/fonc.2023.1185466","volume":"13","author":"J Dong","year":"2023","unstructured":"Dong J, Wang S, Xie H, Mou Y, Zhu H, Peng Y, Xi J, Zhong M, Xie Z, Jiang Z, et al. COVID-19 hospitalization increases the risk of developing glioblastoma: a bidirectional mendelian-randomization study. Front Oncol. 2023;13:1185466.","journal-title":"Front Oncol"},{"issue":"1","key":"575_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/add.16019","volume":"118","author":"X Shi","year":"2023","unstructured":"Shi X, Yuan W, Cao Q, Cui W. Education plays a crucial role in the pathway from poverty to smoking: a mendelian randomization study. Addiction (Abingdon England). 2023;118(1):128\u201339.","journal-title":"Addiction (Abingdon England)"},{"issue":"5","key":"575_CR18","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1177\/0962280215597579","volume":"26","author":"S Burgess","year":"2017","unstructured":"Burgess S, Small DS, Thompson SG. A review of instrumental variable estimators for mendelian randomization. Stat Methods Med Res. 2017;26(5):2333\u201355.","journal-title":"Stat Methods Med Res"},{"issue":"4","key":"575_CR19","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/hep.32183","volume":"75","author":"L Chen","year":"2022","unstructured":"Chen L, Yang H, Li H, He C, Yang L, Lv G. Insights into modifiable risk factors of cholelithiasis: a mendelian randomization study. Hepatology (Baltimore MD). 2022;75(4):785\u201396.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"8","key":"575_CR20","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1093\/brain\/awad070","volume":"146","author":"J Lin","year":"2023","unstructured":"Lin J, Zhou J, Xu Y. Potential drug targets for multiple sclerosis identified through mendelian randomization analysis. Brain. 2023;146(8):3364\u201372.","journal-title":"Brain"},{"issue":"7","key":"575_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658\u201365.","journal-title":"Genet Epidemiol"},{"issue":"R2","key":"575_CR22","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","volume":"27","author":"G Hemani","year":"2018","unstructured":"Hemani G, Bowden J, Davey Smith G. Evaluating the potential role of pleiotropy in mendelian randomization studies. Hum Mol Genet. 2018;27(R2):R195\u2013208.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"575_CR23","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"575_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","volume":"28","author":"S Burgess","year":"2017","unstructured":"Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants. Epidemiol (Cambridge Mass). 2017;28(1):30\u201342.","journal-title":"Epidemiol (Cambridge Mass)"},{"issue":"11","key":"575_CR25","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13(11):e1007081.","journal-title":"PLoS Genet"},{"issue":"1","key":"575_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/ije\/dyr233","volume":"41","author":"CL Relton","year":"2012","unstructured":"Relton CL, Davey Smith G. Two-step epigenetic mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. Int J Epidemiol. 2012;41(1):161\u201376.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"575_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12916-020-01655-1","volume":"18","author":"HE R\u00f6hnisch","year":"2020","unstructured":"R\u00f6hnisch HE, Kyr\u00f8 C, Olsen A, Thysell E, Hallmans G, Moazzami AA. Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study. BMC Med. 2020;18(1):187.","journal-title":"BMC Med"},{"issue":"4","key":"575_CR28","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.eururo.2011.06.016","volume":"60","author":"DD \u00d8rsted","year":"2011","unstructured":"\u00d8rsted DD, Bojesen SE, Nielsen SF, Nordestgaard BG. Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men. Eur Urol. 2011;60(4):691\u20138.","journal-title":"Eur Urol"},{"issue":"10","key":"575_CR29","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1158\/1055-9965.EPI-19-0387","volume":"28","author":"ME Langston","year":"2019","unstructured":"Langston ME, Horn M, Khan S, Pakpahan R, Doering M, Dennis LK, Sutcliffe S. A systematic review and Meta-analysis of associations between clinical prostatitis and prostate Cancer: new estimates Accounting for Detection Bias. Cancer Epidemiol Biomarkers Prevention: Publication Am Association Cancer Res Cosponsored Am Soc Prev Oncol. 2019;28(10):1594\u2013603.","journal-title":"Cancer Epidemiol Biomarkers Prevention: Publication Am Association Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"575_CR30","doi-asserted-by":"publisher","first-page":"682750","DOI":"10.1155\/2013\/682750","volume":"2013","author":"AJ Hennis","year":"2013","unstructured":"Hennis AJ, Wu SY, Nemesure B, Leske MC. Urologic characteristics and sexual behaviors associated with prostate cancer in an african-caribbean population in Barbados, west indies. Prostate cancer. 2013;2013:682750.","journal-title":"Prostate cancer"},{"issue":"1","key":"575_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10552-009-9441-9","volume":"21","author":"S Weinmann","year":"2010","unstructured":"Weinmann S, Shapiro JA, Rybicki BA, Enger SM, Van Den Eeden SK, Richert-Boe KE, Weiss NS. Medical history, body size, and cigarette smoking in relation to fatal prostate cancer. Cancer Causes Control: CCC. 2010;21(1):117\u201325.","journal-title":"Cancer Causes Control: CCC"},{"issue":"1","key":"575_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/13685538.2022.2050360","volume":"25","author":"J Li","year":"2022","unstructured":"Li J, Li Y, Cao D, Huang Y, Peng L, Meng C, Wei Q. The association between histological prostatitis and benign prostatic hyperplasia: a single-center retrospective study. Aging male: Official J Int Soc Study Aging Male. 2022;25(1):88\u201393.","journal-title":"Aging male: Official J Int Soc Study Aging Male"},{"issue":"3","key":"575_CR33","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/ijc.30471","volume":"140","author":"V Nair-Shalliker","year":"2017","unstructured":"Nair-Shalliker V, Yap S, Nunez C, Egger S, Rodger J, Patel MI, O\u2019Connell DL, Sitas F, Armstrong BK, Smith DP. Adult body size, sexual history and adolescent sexual development, may predict risk of developing prostate cancer: results from the New South Wales Lifestyle and evaluation of risk study (CLEAR). Int J Cancer. 2017;140(3):565\u201374.","journal-title":"Int J Cancer"},{"issue":"3","key":"575_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00345-015-1625-1","volume":"34","author":"K Boehm","year":"2016","unstructured":"Boehm K, Valdivieso R, Meskawi M, Larcher A, Schiffmann J, Sun M, Graefen M, Saad F, Parent M, Karakiewicz PI. Prostatitis, other genitourinary infections and prostate cancer: results from a population-based case-control study. World J Urol. 2016;34(3):425\u201330.","journal-title":"World J Urol"},{"issue":"18","key":"575_CR35","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1002\/cncr.26653","volume":"118","author":"JL Wright","year":"2012","unstructured":"Wright JL, Lin DW, Stanford JL. Circumcision and the risk of prostate cancer. Cancer. 2012;118(18):4437\u201343.","journal-title":"Cancer"},{"key":"575_CR36","doi-asserted-by":"crossref","unstructured":"Oseni SO, Naar C, Pavlovi\u0107 M, Asghar W, Hartmann JX, Fields GB, Esiobu N, Kumi-Diaka J. The molecular basis and clinical consequences of chronic inflammation in Prostatic diseases: Prostatitis, Benign Prostatic Hyperplasia, and prostate Cancer. Cancers 2023, 15(12).","DOI":"10.3390\/cancers15123110"},{"issue":"10","key":"575_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41585-021-00496-8","volume":"18","author":"G Fiard","year":"2021","unstructured":"Fiard G, Stavrinides V, Chambers ES, Heavey S, Freeman A, Ball R, Akbar AN, Emberton M. Cellular senescence as a possible link between prostate diseases of the ageing male. Nat Reviews Urol. 2021;18(10):597\u2013610.","journal-title":"Nat Reviews Urol"},{"key":"575_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.euros.2022.07.004","volume":"43","author":"A Glaser","year":"2022","unstructured":"Glaser A, Shi Z, Wei J, Lanman NA, Ladson-Gary S, Vickman RE, Franco OE, Crawford SE, Lilly Zheng S, Hayward SW, et al. Shared inherited Genetics of Benign Prostatic Hyperplasia and prostate Cancer. Eur Urol open Sci. 2022;43:54\u201361.","journal-title":"Eur Urol open Sci"},{"issue":"4","key":"575_CR39","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.eururo.2007.06.038","volume":"52","author":"A Sciarra","year":"2007","unstructured":"Sciarra A, Di Silverio F, Salciccia S, Autran Gomez AM, Gentilucci A, Gentile V. Inflammation and chronic prostatic diseases: evidence for a link? Eur Urol. 2007;52(4):964\u201372.","journal-title":"Eur Urol"},{"issue":"1","key":"575_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.eururo.2004.08.024","volume":"47","author":"F Di Silverio","year":"2005","unstructured":"Di Silverio F, Bosman C, Salvatori M, Albanesi L, Proietti Pannunzi L, Ciccariello M, Cardi A, Salvatori G, Sciarra A. Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Eur Urol. 2005;47(1):72\u20138. discussion 78\u201379.","journal-title":"Eur Urol"},{"issue":"2 Pt 2","key":"575_CR41","first-page":"S59","volume":"171","author":"JW Basler","year":"2004","unstructured":"Basler JW, Piazza GA. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemoprevention. J Urol. 2004;171(2 Pt 2):S59\u201362. discussion S62-53.","journal-title":"J Urol"},{"issue":"5","key":"575_CR42","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/bju.13612","volume":"119","author":"JF Flamiatos","year":"2017","unstructured":"Flamiatos JF, Beer TM, Graff JN, Eilers KM, Tian W, Sekhon HS, Garzotto M. Cyclooxygenase-2 (COX-2) inhibition for prostate cancer chemoprevention: double-blind randomised study of pre-prostatectomy celecoxib or placebo. BJU Int. 2017;119(5):709\u201316.","journal-title":"BJU Int"},{"issue":"4","key":"575_CR43","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.urology.2008.06.032","volume":"72","author":"R Rittmaster","year":"2008","unstructured":"Rittmaster R, Hahn RG, Ray P, Shannon JB, Wurzel R. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer. Urology. 2008;72(4):808\u201312.","journal-title":"Urology"},{"issue":"3","key":"575_CR44","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.urology.2011.03.063","volume":"78","author":"CG Roehrborn","year":"2011","unstructured":"Roehrborn CG, Nickel JC, Andriole GL, Gagnier RP, Black L, Wilson TH, Rittmaster RS. Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer events (REDUCE) trial. Urology. 2011;78(3):641\u20136.","journal-title":"Urology"},{"issue":"4","key":"575_CR45","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.juro.2016.11.090","volume":"197","author":"CM Moore","year":"2017","unstructured":"Moore CM, Robertson NL, Jichi F, Damola A, Ambler G, Giganti F, Ridout AJ, Bott SR, Winkler M, Ahmed HU, et al. The Effect of Dutasteride on magnetic resonance imaging defined prostate Cancer: MAPPED-A Randomized, Placebo Controlled, double-blind clinical trial. J Urol. 2017;197(4):1006\u201313.","journal-title":"J Urol"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-024-00575-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-024-00575-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-024-00575-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T03:04:44Z","timestamp":1734577484000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-024-00575-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["575"],"URL":"https:\/\/doi.org\/10.1186\/s13062-024-00575-x","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}